"Strategic alliances, collaborations and key intellectual property license arrangements play a key role in the ever-evolving life sciences industry. Recent years have seen a sharp increase in global biotech and pharmaceutical companies partnering
with smaller companies to collaborate much earlier in the development process. Highlighting recent high-profile earlystage collaborations and analyzing notable alliance successes
and failures, this panel presentation will suggest proactive strategies and tactics to improve the odds of success."

Objective1: Prepare for the main risks and challenges presented by emerging markets.

Objective2: Understand actionable best practices and insights to help build organizational capabilities and improve deal processes.

Objective3: Learn from other industries what contributes to success and failure in emerging markets transactions.